A more recent study that combines tissue microarray (TMA) and DNA analysis found that different types of p53 alterations characterize subgroups of prostate cancer with distinctively different prognoses; strong p53 immunostaining is rare but represents an independent and worse prognostic event in prostate cancer 47. The gene discussed is TP53; the disease is prostate cancer.